Novel compounds

An isolated antibody having specific for a target structure displayed on the surface of human gastrointestinal epithelial tumour cells, with the binding domain complementarity determining region (CDR) sequences in the light chain comprising amino acids 23-33 (CDR1), 49- 55 (CDR2), 88-98 (CDR3) of SE...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	KARLSTROM, PIA J, OHLSSON, LENNART G, NILSON, BO H K, ORDSSON, M JESPER, KEARNEY, PHILIP P, BRODIN, THOMAS
Format:	Patent
Sprache:	eng
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PHYSICS PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS TESTING VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	An isolated antibody having specific for a target structure displayed on the surface of human gastrointestinal epithelial tumour cells, with the binding domain complementarity determining region (CDR) sequences in the light chain comprising amino acids 23-33 (CDR1), 49- 55 (CDR2), 88-98 (CDR3) of SEQ ID NO:2, and the binding domain CDR of the heavy chain comprising amino acids 158- 162 (CDR1), 177-193 (CDR2), 226-238 (CDR3) of SEQ ID NO:2.